Ex Parte ISHIKAWA et al - Page 14




          Appeal No. 1997-3361                                                       
          Application No. 08/554,939                                                 


          substrate, any silver halide emulsion, any processing condition,           
          any thiosulfate, a large number of possible compounds of formula           
          (I), and wide ranges of amounts for the thiosulfate and the                
          compound of formula (I).  For example, as pointed out by the               
          examiner (examiner’s answer, page 17), the appellants have not             
          presented sufficient evidence that would establish unobvious               
          results for the entire claimed ranges of amounts for the                   
          thiosulfate and the compound of formula (I), e.g. about 0.001              
          mol/liter of a thiosulfate.  Under these circumstances, we                 
          determine that appellants’ showing of unexpected results is far            
          from being commensurate in scope with the degree of patent                 
          protection sought.  In re Kulling, 897 F.2d 1147, 1149, 14 USPQ2d          
          1056, 1058 (Fed. Cir. 1990)(“[O]bjective evidence of                       
          nonobviousness must be commensurate in scope with the claims. ”)           
          (quoting In re Lindner, 457 F.2d 506, 508, 173 USPQ 356, 358               
          (CCPA 1972); In re Dill, 604 F.2d 1356, 1361, 202 USPQ 805, 808            
          (CCPA 1979) (“The evidence presented to rebut a prima facie case           
          of obviousness must be commensurate in scope with the claims to            
          which it pertains.”).                                                      
               For these reasons, we affirm each of the examiner’s                   
          rejections under 35 U.S.C. § 103.                                          
               In summary, we reverse the examiner’s rejection under 35              
          U.S.C. § 102 of claims 1, 7, 8, and 9 as anticipated by Kojima             

                                         14                                          





Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007